This trial will test if a low dose of a fluorine-18-based NP-59 can be used to image the adrenal gland in healthy people and people with adrenal conditions.
1 Primary · 1 Secondary · Reporting Duration: Day 4
Experimental Treatment
24 Total Participants · 3 Treatment Groups
Primary Treatment: PET/CT Scan with FNP-59 · No Placebo Group · Phase < 1
Age 18+ · All Participants · 1 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you: